Literature DB >> 10892754

Interferon plus chemotherapy for primary treatment of ovarian cancer.

J S Berek1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10892754     DOI： 10.1016/S0140-6736(00)02422-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decade.

Authors:  Lana E Kandalaft; Nathan Singh; John B Liao; Andrea Facciabene; Jonathan S Berek; Daniel J Powell; George Coukos
Journal:  Gynecol Oncol       Date:  2009-12-02       Impact factor: 5.482

Review 2.  Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer.

Authors:  Aramide O Lawal; Alfred Musekiwa; Liesl Grobler
Journal:  Cochrane Database Syst Rev       Date:  2013-06-06

Review 3.  Chimeric Peptides/Proteins Encoded by circRNA: An Update on Mechanisms and Functions in Human Cancers.

Authors:  Faiz Ali Khan; Bernard Nsengimana; Nazeer Hussain Khan; Zhenhua Song; Ebenezeri Erasto Ngowi; Yunyun Wang; Weijuan Zhang; Shaoping Ji
Journal:  Front Oncol       Date:  2022-02-11       Impact factor: 6.244

Review 4.  Peptides/Proteins Encoded by Non-coding RNA: A Novel Resource Bank for Drug Targets and Biomarkers.

Authors:  Song Zhu; Jizhong Wang; Yutian He; Nan Meng; Guang-Rong Yan
Journal:  Front Pharmacol       Date:  2018-11-13       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.